Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 2,193 shares at $7.76 ($17K) on 2023-03-20, disclosed to the SEC on 2023-03-22.
Scheduled sale ($17k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |